Thrombolex, Inc.’s Post

#TCT2024: Large-bore mechanical thrombectomy vs catheter-directed thrombolysis for treatment of intermediate-risk pulmonary embolism What do you think would be the future of catheter-directed treatment in patients with acute intermediate-risk PE? Do you think LBMT is better than CDT for its treatment? Read this review by Elad Asher of the results of the PEERLESS trial, presented by Wissam A Jaber in Washington ➡ https://lnkd.in/duVHF_eQ #interventionalcardiology #pulmonaryembolism #clinicaltrials

The RESCUE-II trial highlights the impact of a ground breaking, on-the-table treatment. With an advanced design that effectively treats the subsegmental pulmonary arteries, the BASHIR™ Endovascular Catheter delivers targeted thrombolytics, resulting in safer, precise clot resolution. Discover how this approach is redefining pulmonary embolism care. https://lnkd.in/ejaKThHM Thrombolex.com #Thrombolex

4. #2024Top10 Clinical Image: Transcatheter Closure of a Coronary Artery to Pulmonary Artery Fistula With Two Sequential Giant Aneurysms ▶️https://okt.to/ensmVP

👇Transbaffle Puncture for Mapping and Ablation of Arrhythmia in TGA patients After Mustard Correction👇 #EPeeps Here is an overview of one of my favorite procedures: arrhythmia ablation after Mustard correction (In 6 steps): 👉 Step 1: Perform baffle angiography. 👉 Step 2: Monitor pressure during puncture of the lower portion of the baffle. 👉 Step 3: Insert the wire into the RSPV. 👉 Step 4: Advance the sheath over the wire into the pulmonary venous atrium. 👉 Step 5: Introduce the mapping catheter into the RSPV (and carefully assess the signals). 👉 Step 6: Perform angiography of the RSPV. 👉 Final Step: Enjoy the procedure! 👈 Philipp Sommer Stephan Molatta Dr.med. Vanessa Sciacca Thomas Fink Moneeb Khalaph Maxim Didenko, MD Abbott Medinbox AGEP_DGK Stephan Winnik Alessandro Parlato

📓 New From The Texas Heart Institute Journal A patient with PE complicated by cardiogenic shock benefitted from VA-ECMO stabilization before large-bore catheter aspiration thrombectomy. Hugh Glazier, MB and Amir Kaki, MD describe a treatment strategy informed by PE response team (PERT) concerns. #THIJournal #pulmonaryembolism #ECMO #cardiogenicshock Read the paper: https://lnkd.in/gyijwwXz

A QFR-guided revascularization strategy did not provide the same prognostic benefits as an FFR-guided strategy for patients with intermediate coronary stenosis, based on findings from the FAVOR III Europe trial presented at #TCT2024. Get the details: https://bit.ly/3YIXYZF #ACCIC

📌NEW ISSUE OUT📌 ✅The 18th EBC consensus document; ✅Morphofunctional assessment in ACS patients; ✅OCT-guided PCI in STEMI patients; ✅A debate on bivalirudin; ✅The A-Flux − a selfexpanding coronary sinus reducer; ✅5-year outcomes of the ACURATE neo AS study; and more https://ow.ly/7Ipz50SQXTu

Recent European guidelines endorsed QFR to guide revascularization decisions for intermediate coronary stenoses. However, the randomized FAVOR III Europe trial showed that a QFR-guided strategy failed to meet non-inferiority to FFR for major adverse cardiac events. This may result from either false-negative QFR leading to missed stenting or false-positive QFR leading to unnecessary stenting, both theoretically increasing risk. The clinical benefit of physiology-based revascularization largely stems from avoiding unnecessary interventions. While the safety of deferring revascularization with wire-based indices is well established, it remains uncertain for QFR. This key subanalysis of FAVOR III Europe highlights that a routine QFR-guided strategy may not ensure the same safety in deferring revascularization for intermediate stenoses as FFR. https://lnkd.in/ddjkS6TK

In everything we do, we believe in thinking differently. We believe in challenging the status quo. We create innovative interventional technologies designed to treat VTE that are elegantly simple, very safe, and highly effective. Discover how an easy-to-use, single session pharmacomechanical (PML) technology can help you do more for your pulmonary embolism patients with less. Thrombolex.com #Thrombolex